Mark Emberton is Professor of Interventional Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London. He is clinically active and holds the position of Honorary Consultant Urologist at University College London Hospitals NHS Trust where he works as a specialist in prostate cancer.

His academic work has focused on developing novel diagnostic strategies and new therapies for men with prostate cancer. His research has resulted in the transformation of both the diagnostic and therapeutic pathways. These have been incorporated into international guidelines.

He has published over 500 peer review papers, holds a large grant portfolio, and lectures widely around the world and holds international honorary professorships.

He is a founding Pioneer of the charity Prostate Cancer UK.

  • Declaration of interests:
  • Consultancy advice to:
  • Sonacare Medical
  • Angiodynamics
  • NINA Medical
  • Profound Medical
  • Exact Imaging
  • Minomic Medical
  • Proteomix
  • Prostate cancer care undertaken at King Edward VII Hospital (London Urology Specialists)
  • All current research is Grant Council sponsored. Within the MRC / CRUK Re-IMAGINE trial we receive £8million of in-kind industry contribution managed through the MRC MICA process.